the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Axicabtagene Ciloleucel Expanded Access Study
Official Title Multicenter, Open-label, Expanded Access Study of Axicabtagene Ciloleucel for the Treatment of Relapsed/Refractory Transplant-Ineligible Aggressive Non-Hodgkin Lymphoma (NHL)
Principal Investigator Riedell, Peter
Brief Summary This is a multicenter, open-label expanded access protocol for the treatment of subjects with relapsed/refractory transplant ineligible aggressive NHL.
Gender All
Ages 18 Years
Enrollment Hello Null!
Accepts Healthy Volunteers
Lead Sponsor Kite Pharma, Inc.Industry
Collaborator
Study Design
Study Phase N/A
Study Type Expanded Access
Contact Name Peter Reidell, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Relapsed/Refractory Transplant Ineligible Diffuse Large B Cell Lymphoma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI